FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4295678552> ?p ?o ?g. }

• W4295678552 abstract "Sodium-glucose cotransporter 2 inhibitors could reduce cardiovascular events in patients with heart failure irrespective of diabetes status. In this prespecified sub-analysis of randomised-controlled trial, we investigated the efficacy of luseogliflozin (2.5 mg daily), a sodium-glucose cotransporter 2 inhibitor, with that of voglibose (0.6 mg daily), an alpha-glucosidase inhibitor, on high-risk lipid profile and inflammatory markers in patients with type-2 diabetes and heart failure. Among the 157 patients studied, there were no significant differences in the mean malondialdehyde LDL or small-dense LDL cholesterol levels between the luseogliflozin and voglibose groups (percent change: 0.2% vs. - 0.6%, p = 0.93; - 1.7% vs. - 8.6%, p = 0.21) after 12 weeks in comparison to levels at the baseline. No significant difference was observed between the two groups in the adiponectin and high-sensitivity C-reactive protein levels after 12 weeks compared to the baseline levels (percent change, - 1.6% vs. - 4.0% and 22.5% vs. 10.0%; p = 0.52 and p = 0.55, respectively). In conclusion, in patients with type-2 diabetes and heart failure, compared to voglibose, luseogliflozin did not significantly improve the high-risk lipoprotein profile including malondialdehyde LDL and small-dense LDL cholesterol or the levels of inflammatory markers, including adiponectin and high-sensitivity C-reactive protein.Trial registration: Trial number: UMIN-CTR, UMIN000018395; Registered 23 July 2015; URL: https://www.umin.ac.jp/ctr/index.htm ." @default.
• W4295678552 created "2022-09-14" @default.
• W4295678552 creator A5000478646 @default.
• W4295678552 creator A5004033887 @default.
• W4295678552 creator A5005354557 @default.
• W4295678552 creator A5009299884 @default.
• W4295678552 creator A5010935139 @default.
• W4295678552 creator A5011680174 @default.
• W4295678552 creator A5016628988 @default.
• W4295678552 creator A5029731768 @default.
• W4295678552 creator A5034976943 @default.
• W4295678552 creator A5035680893 @default.
• W4295678552 creator A5038748850 @default.
• W4295678552 creator A5038761025 @default.
• W4295678552 creator A5039038875 @default.
• W4295678552 creator A5041781671 @default.
• W4295678552 creator A5044544721 @default.
• W4295678552 creator A5058119107 @default.
• W4295678552 creator A5059830493 @default.
• W4295678552 creator A5061841627 @default.
• W4295678552 creator A5065215172 @default.
• W4295678552 creator A5067787217 @default.
• W4295678552 creator A5068575065 @default.
• W4295678552 creator A5069940779 @default.
• W4295678552 creator A5074229201 @default.
• W4295678552 creator A5078019975 @default.
• W4295678552 creator A5083932381 @default.
• W4295678552 date "2022-09-14" @default.
• W4295678552 modified "2023-10-14" @default.
• W4295678552 title "Effects of luseogliflozin and voglibose on high-risk lipid profiles and inflammatory markers in diabetes patients with heart failure" @default.
• W4295678552 cites W1996977133 @default.
• W4295678552 cites W1998780302 @default.
• W4295678552 cites W2007832417 @default.
• W4295678552 cites W2009741614 @default.
• W4295678552 cites W2017602185 @default.
• W4295678552 cites W2038120135 @default.
• W4295678552 cites W2038270027 @default.
• W4295678552 cites W2067261742 @default.
• W4295678552 cites W2094715388 @default.
• W4295678552 cites W2100068451 @default.
• W4295678552 cites W2116404316 @default.
• W4295678552 cites W2127307547 @default.
• W4295678552 cites W2145805916 @default.
• W4295678552 cites W2146264128 @default.
• W4295678552 cites W2148513135 @default.
• W4295678552 cites W2148910374 @default.
• W4295678552 cites W2324385605 @default.
• W4295678552 cites W2475261460 @default.
• W4295678552 cites W2492672367 @default.
• W4295678552 cites W2576291926 @default.
• W4295678552 cites W2603386412 @default.
• W4295678552 cites W2614137535 @default.
• W4295678552 cites W2626446274 @default.
• W4295678552 cites W2790286202 @default.
• W4295678552 cites W2890539106 @default.
• W4295678552 cites W2899764361 @default.
• W4295678552 cites W2900413769 @default.
• W4295678552 cites W2909093692 @default.
• W4295678552 cites W2927471579 @default.
• W4295678552 cites W2941293571 @default.
• W4295678552 cites W2974260792 @default.
• W4295678552 cites W3046604383 @default.
• W4295678552 cites W3081830235 @default.
• W4295678552 cites W3088446089 @default.
• W4295678552 cites W3089283105 @default.
• W4295678552 doi "https://doi.org/10.1038/s41598-022-19371-6" @default.
• W4295678552 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36104378" @default.
• W4295678552 hasPublicationYear "2022" @default.
• W4295678552 type Work @default.
• W4295678552 citedByCount "6" @default.
• W4295678552 countsByYear W42956785522022 @default.
• W4295678552 countsByYear W42956785522023 @default.
• W4295678552 crossrefType "journal-article" @default.
• W4295678552 hasAuthorship W4295678552A5000478646 @default.
• W4295678552 hasAuthorship W4295678552A5004033887 @default.
• W4295678552 hasAuthorship W4295678552A5005354557 @default.
• W4295678552 hasAuthorship W4295678552A5009299884 @default.
• W4295678552 hasAuthorship W4295678552A5010935139 @default.
• W4295678552 hasAuthorship W4295678552A5011680174 @default.
• W4295678552 hasAuthorship W4295678552A5016628988 @default.
• W4295678552 hasAuthorship W4295678552A5029731768 @default.
• W4295678552 hasAuthorship W4295678552A5034976943 @default.
• W4295678552 hasAuthorship W4295678552A5035680893 @default.
• W4295678552 hasAuthorship W4295678552A5038748850 @default.
• W4295678552 hasAuthorship W4295678552A5038761025 @default.
• W4295678552 hasAuthorship W4295678552A5039038875 @default.
• W4295678552 hasAuthorship W4295678552A5041781671 @default.
• W4295678552 hasAuthorship W4295678552A5044544721 @default.
• W4295678552 hasAuthorship W4295678552A5058119107 @default.
• W4295678552 hasAuthorship W4295678552A5059830493 @default.
• W4295678552 hasAuthorship W4295678552A5061841627 @default.
• W4295678552 hasAuthorship W4295678552A5065215172 @default.
• W4295678552 hasAuthorship W4295678552A5067787217 @default.
• W4295678552 hasAuthorship W4295678552A5068575065 @default.
• W4295678552 hasAuthorship W4295678552A5069940779 @default.
• W4295678552 hasAuthorship W4295678552A5074229201 @default.
• W4295678552 hasAuthorship W4295678552A5078019975 @default.
• W4295678552 hasAuthorship W4295678552A5083932381 @default.
• W4295678552 hasBestOaLocation W42956785521 @default.
• W4295678552 hasConcept C126322002 @default.

• next